A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases

Conditions

• Epstein-Barr Virus (EBV)-Associated Diseases
• EBV+ Lymphoproliferative Disease With Primary Immunodeficiency (EBV+ PID LPD)
• EBV+ Lymphoproliferative Disease With Acquired (Non-congenital) Immunodeficiency (EBV+ AID LPD)
• EBV+ Posttransplant Lymphoproliferative Disease in Central Nervous System (EBV+ CNS PTLD)
• EBV+ Post-transplant Lymphoproliferative Disease (EBV+ PTLD)
• Solid Organ Transplant Complications
• Lymphoproliferative Disorders
• Allogeneic Hematopoietic Cell Transplant
• Stem Cell Transplant Complications
• EBV+ Sarcomas
• Leiomyosarcoma

Interventions

• BIOLOGICAL: Tabelecleucel

Sponsor

Pierre Fabre Medicament